Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

KMK Consulting/

Library

KMK Consulting

KMK Consulting Website, Blog & Press Pages - aVenture Research

Library

kmkconsultinginc.comCrawled Nov 9, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

KMK's incentive compensation solutions - Split Credit Tool/kmks-split-credit-tool-improves-ic-performance
The Split Credit Tool improves incentive compensation effectiveness by centralizing data for representatives.
Prescribed solution to achieve strategic objectives in pharma/data-rx-your-prescribed-solution-to-achieve-strategic-objectives-in-emerging-pharma
Data Rx provides data-driven solutions for strategic objectives in emerging pharmaceutical markets.
Resolving data challenges with data management and analytics/resolving-data-challenges-with-end-to-end-data-management-and-analytics
A global pharmaceutical company was expanding into the U.S. market and was being hampered in its efforts due to the data management system they were using.
SFE service offering/sfe-service-offering

Blog

6 pages

Agile Market Research – The Way to Faster Results/agile-market-research-approaches-the-way-to-faster-results
Customer Value & Innovation in Oncology - Case Study/how-to-reach-oncologists-when-face-to-face-interaction-is-impossible
The page discusses customer value in oncology and strategies for engaging oncologists remotely.
Leveraging Anonymized Patient Level Data - Case Study/leverage-anonymized-patient-level-data-apld-to-identify-market-opportunities
The company used anonymized patient-level data and analytics to help a client recover from a stagnant product launch.
Real World Evidence to Support Payer Negotiation/real-world-evidence-to-support-payer-negotiation
The company assisted a large global pharmaceutical client in proving their product’s value to negotiate pricing with payers in a competitive therapeutic category.

Press

6 pages

Great Place to Work in India 2024 certified/kmk-has-once-again-been-named-a-great-place-to-work-in-india-2024
Intellus Worldwide Summit 2024/intellus-worldwide-summit-2024
The company provides market insights and analytics to help stakeholders navigate an evolving marketplace.
ISPOR 2024/ispor-2024
KMK Named a Great Place to work in the US in 2023/kmk-consulting-inc-earns-third-consecutive-us-great-place-to-work-certification-in-2023

Careers & Hiring

4 pages

Employee Spotlight/employee-spotlight
The page highlights KMK Consulting Inc’s team through an Employee Spotlight.
Explore Careers and Job Opportunities with KMK/careers
Life at KMK/life-at-kmk
where a culture of innovation, teamwork, and career development empowers employees to achieve their fullest potential.
Life at KMK India/life-at-kmk-india

Team

6 pages

Devon Reimer/kun-liu
Technology should be at the service of people, not the other way around.
Jing Yu/jing-yu
Jing Yu consults on product launch planning, forecasting, and related strategies.
Melissa Archuleta/melissa-archuleta
Melissa specializes in human resources and pairs clients with KMK teams to meet their business goals.
Michael Karbachinskiy/michael-karbachinskiy
Michael founded KMK to provide clients with real-world, feasible solutions.

About

1 page

Pharma commercialization success/why-kmk
KMK provides the data and analysis needed to help drive pharma business decisions and improve efficiency and effectiveness of commercial analytics and sales operations.

Contact

1 page

Contact Us/contact-us
The company offers pharma commercial strategy solutions aligned with business objectives.

Homepage

1 page

Homepage/
KMK provides research, analytics, and software solutions for pharmaceutical companies.

Privacy

1 page

Privacy Policy/privacy-policy
The company’s pharma privacy policy ensures data security, confidentiality, and compliance.

Terms & Conditions

1 page

Terms of Use/terms-of-use
The page outlines the company’s Terms of Use, detailing user rights and responsibilities.